Will Hulme
Statistician
Will is a statistician focusing on the OpenSAFELY research platform since joining in April 2020. He is interested in improving how routinely-collected health data can be used for prediction and inference, also in improving transparency and reusability of research data and code. He has a BSc in Mathematics and an MSc in Operational Research from the University of Edinburgh and a PhD from the University of Manchester. He has held various research and teaching roles in academia, the NHS, and non-profits, and is a Software Sustainability Institute 2020 Fellow.
Papers by Will Hulme
(PRE-PRINT) Consistency, completeness and external validity of ethnicity recording in NHS primary care records: a cohort study in 25 million patients’ records at source using OpenSAFELY
(PRE-PRINT) Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY
(PRE-PRINT) The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.
Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults’ primary care records in England through OpenSAFELY
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
(PRE-PRINT) OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?
Blogs by Will Hulme
Challenges in Estimating COVID-19 Vaccine Effectiveness Using Observational Data
